| Product NDC: | 0069-2600 | 
| Proprietary Name: | Procardia | 
| Non Proprietary Name: | NIFEDIPINE | 
| Active Ingredient(s): | 10 mg/1 & nbsp; NIFEDIPINE | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | CAPSULE | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0069-2600 | 
| Labeler Name: | Pfizer Laboratories Div Pfizer Inc | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA018482 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 19811231 | 
| Package NDC: | 0069-2600-66 | 
| Package Description: | 100 CAPSULE in 1 BOTTLE (0069-2600-66) | 
| NDC Code | 0069-2600-66 | 
| Proprietary Name | Procardia | 
| Package Description | 100 CAPSULE in 1 BOTTLE (0069-2600-66) | 
| Product NDC | 0069-2600 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | NIFEDIPINE | 
| Dosage Form Name | CAPSULE | 
| Route Name | ORAL | 
| Start Marketing Date | 19811231 | 
| Marketing Category Name | NDA | 
| Labeler Name | Pfizer Laboratories Div Pfizer Inc | 
| Substance Name | NIFEDIPINE | 
| Strength Number | 10 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient] |